To ask the Scottish Government when guidance will be issued to NHS boards to update the current Guidance to Further Strengthen the Safe and Effective Use of New Medicines across the NHS in Scotland, as issued in Chief Medical Officer's letter CMO (2012) 1, and associated guidance, including the timescale and implementation of Scottish Medicines Consortium advice at a local level.